| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $982,190 ) |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K99AG086524 | Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age | 000 | 2 | NIH | 12/10/2025 | $135,057 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI183676 | Defining the Regulatory Landscape of Lupus with CVD Comorbidity | 000 | 2 | NIH | 11/26/2025 | $847,133 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35HL145237 | Translational Control of Megakaryocyte and Platelet Gene Expression in Disease | 000 | 7 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 001 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 000 | 5 | NIH | 11/20/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $45,035,256 ) (Continued on the next page) |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 007 | 4 | NIH | 9/16/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 002 | 4 | NIH | 3/31/2025 | $1 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 006 | 4 | NIH | 9/15/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 004 | 4 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 4 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 4 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 4 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $100,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $1 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $150,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI172255 | Contributions of autophagy-related genes in lupus | 000 | 3 | NIH | 8/5/2025 | $737,898 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI172255 | Contributions of autophagy-related genes in lupus | 001 | 3 | NIH | 8/19/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AG087622 | Determining the influence of metformin treatment on mitochondrial calcium flux during aerobic exercise training of healthy, aging rats | 000 | 2 | NIH | 6/24/2025 | $50,690 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | U01AI176244 | Autoimmune Drivers and Protectors Team Science (ADAPTS) | 000 | 3 | NIH | 1/23/2025 | $1,249,430 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY034946 | Retinal Pigmented Epithelium Epigenome Dysregulation With Aging and Modulation by Diet | 000 | 2 | NIH | 1/23/2025 | $536,749 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG081855 | Mitochondrial NAD+ Metabolism in Cardiac Aging | 001 | 2 | NIH | 7/22/2025 | $47,928 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG081855 | Mitochondrial NAD+ Metabolism in Cardiac Aging | 000 | 2 | NIH | 12/24/2024 | $539,182 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG077812 | A novel role for oxidized lipid mediators as effectors of muscle atrophy and weakness in aging | 000 | 4 | NIH | 8/19/2025 | $535,985 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DA060226 | Effects of tobacco smoking on prognosis and immune function in multiple sclerosis | 000 | 1 | NIH | 5/16/2025 | $552,147 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 002 | 4 | NIH | 8/12/2025 | $47,691 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 001 | 4 | NIH | 12/19/2024 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 000 | 4 | NIH | 12/18/2024 | $536,527 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY033782 | Interrogating the intersection between diet and ocular autoimmunity | 000 | 4 | NIH | 4/3/2025 | $541,165 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | DP5OD033443 | Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging | 002 | 4 | NIH | 8/28/2025 | $1 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | DP5OD033443 | Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging | 002 | 4 | NIH | 8/28/2025 | $873,999 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074551 | Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging | 000 | 4 | NIH | 7/10/2025 | $629,177 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL160955 | Increasing glycolysis in the diabetic heart is cardioprotective and improves glucose tolerance | 000 | 4 | NIH | 8/29/2025 | $437,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM156711 | Center for Genomic Regulation | 000 | 1 | NIH | 6/10/2025 | $2,463,036 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG070035 | Role of estrogen receptor-a in aging and sex-specific responses to 17a-estradiol | 001 | 5 | NIH | 6/11/2025 | $41,239 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG070035 | Role of estrogen receptor-a in aging and sex-specific responses to 17a-estradiol | 000 | 5 | NIH | 5/7/2025 | $463,921 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01NS121298 | Role of ATAD3A in Lysosomal Homeostasis and Neurogenesis | 000 | 5 | NIH | 8/14/2025 | $433,300 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K01AR077684 | The role of Fbxl22 in the regulation of skeletal muscle mass | 000 | 5 | NIH | 5/7/2025 | $120,420 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI156724 | Disease and Race Specific Single-cell Epigenetic Mechanisms in Human SLE | 000 | 5 | NIH | 4/16/2025 | $760,427 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR076440 | Peripheral blood mononuclear cell epigenetic associations in and biomarkers for knee osteoarthritis development and progression | 001 | 7 | NIH | 8/7/2025 | $1,729,917 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35HL144605 | Protease-Mediated Vascular Instability in Development and Disease | 000 | 7 | NIH | 8/8/2025 | $844,478 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P30AR073750 | Oklahoma Rheumatic Disease Research Cores Center | 000 | 8 | NIH | 9/18/2025 | $767,249 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 002 | 6 | NIH | 3/24/2025 | $460,350 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI190169 | Resolving the mechanisms of IFIH1 risk variant in systemic lupus erythematosus | 000 | 1 | NIH | 9/3/2025 | $700,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI190169 | Resolving the mechanisms of IFIH1 risk variant in systemic lupus erythematosus | 000 | 1 | NIH | 9/3/2025 | $2,430,679 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI191517 | Functional and Mechanistic Characterization of Lupus Susceptibility | 000 | 1 | NIH | 9/3/2025 | $3,364,935 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | RF1AG090599 | A role for mitochondrial AMPK signaling in neurons | 000 | 1 | NIH | 9/10/2025 | $2,602,940 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM154839 | Novel pathways in heterochromatin regulation | 000 | 1 | NIH | 8/12/2025 | $426,250 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HD110990 | Development of a lacO/lacI based fluorescence reporter-operator system to study chromosome dynamics and double-strand break repair in mouse meiosis. | 001 | 3 | NIH | 4/25/2025 | $36,657 |
|
